| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
8,964 |
6,920 |
$733K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
1,204 |
982 |
$47K |
| 99499 |
|
109 |
109 |
$3K |
| G2025 |
Payment for a telehealth distant site service furnished by a rural health clinic (rhc) or federally qualified health center (fqhc) only |
335 |
93 |
$2K |
| 90688 |
|
16 |
16 |
$716.80 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
50 |
42 |
$202.80 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
386 |
247 |
$154.13 |
| G0071 |
Payment for communication technology-based services for 5 minutes or more of a virtual (non-face-to-face) communication between an rural health clinic (rhc) or federally qualified health center (fqhc) practitioner and rhc or fqhc patient, or 5 minutes or more of remote evaluation of recorded video and/or images by an rhc or fqhc practitioner, occurring in lieu of an office visit; rhc or fqhc only |
31 |
31 |
$122.19 |
| 90686 |
|
17 |
12 |
$103.94 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
747 |
285 |
$0.00 |
| 3078F |
|
35 |
33 |
$0.00 |
| 3077F |
|
15 |
14 |
$0.00 |
| 81002 |
|
16 |
12 |
$0.00 |
| 1159F |
|
62 |
57 |
$0.00 |
| 1160F |
|
62 |
57 |
$0.00 |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
189 |
85 |
$0.00 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
30 |
15 |
$0.00 |
| 87428 |
|
258 |
216 |
$0.00 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
24 |
22 |
$0.00 |
| G0008 |
Administration of influenza virus vaccine |
16 |
16 |
$0.00 |